{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:08:56Z","timestamp":1785766136110,"version":"3.56.0"},"reference-count":43,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/etm.2016.3391","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T12:30:22Z","timestamp":1464179422000},"page":"840-846","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for symptomatic osteonecrosis in childhood ALL: A retrospective study of a Slovenian pediatric ALL population between 1970 and 2004"],"prefix":"10.3892","volume":"12","author":[{"given":"Nata\u0161a","family":"Karas-Ku\u017eeli\u010dki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mencej-Bedra\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janez","family":"Jazbec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janja","family":"Marc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Mlinari\u010d-Ra\u0161\u010dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"key20180108133137_b1-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejca.2006.11.002","article-title":"Osteonecrosis in children and adolescents with cancer-an adverse effect of systemic therapy","volume":"43","author":"Sala","year":"2007","journal-title":"Eur J Cancer"},{"key":"key20180108133137_b2-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2007.14.9088","article-title":"Osteonecrosis in adult survivors of childhood cancer: A report from the childhood cancer survivor study","volume":"26","author":"Kadan-Lottick","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108133137_b3-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2005.02263.x","article-title":"Skeletal morbidity in childhood acute lymphoblastic leukaemia","volume":"63","author":"Davies","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20180108133137_b4-etm-0-0-3391","first-page":"1096","article-title":"Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy","volume":"91","author":"Faraci","year":"2006","journal-title":"Haematologica"},{"key":"key20180108133137_b5-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s002230020039","article-title":"In vitro effects of chemotherapeutic agents on human osteoblast-like cells","volume":"70","author":"Davies","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"key20180108133137_b6-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1359\/jbmr.2002.17.6.1073","article-title":"Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia","volume":"17","author":"Tillmann","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key20180108133137_b7-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1203\/00006450-199904010-00014","article-title":"Relative osteopenia after treatment for acute lymphoblastic leukemia","volume":"45","author":"Warner","year":"1999","journal-title":"Pediatr Res"},{"key":"key20180108133137_b8-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1200\/JCO.2004.11.020","article-title":"Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia","volume":"22","author":"Relling","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108133137_b9-etm-0-0-3391","first-page":"111","article-title":"The 677C->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head","volume":"87","author":"Zalavras","year":"2002","journal-title":"Haematologica"},{"key":"key20180108133137_b10-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2007-11-123885","article-title":"Children's Oncology Group: A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: A report from the Children's Oncology Group","volume":"111","author":"French","year":"2008","journal-title":"Blood"},{"key":"key20180108133137_b11-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.blre.2015.01.001","article-title":"Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy","volume":"29","author":"Mei","year":"2015","journal-title":"Blood Rev"},{"key":"key20180108133137_b12-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"key20180108133137_b13-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","author":"Glueck","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"key20180108133137_b14-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1101\/gad.1449506","article-title":"Genetic regulation of bone mass and susceptibility to osteoporosis","volume":"20","author":"Ralston","year":"2006","journal-title":"Genes Dev"},{"key":"key20180108133137_b15-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.292.17.2105","article-title":"Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes","volume":"292","author":"Ioannidis","year":"2004","journal-title":"JAMA"},{"key":"key20180108133137_b16-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1371\/journal.pmed.0030090","article-title":"Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: The GENOMOS study","volume":"3","author":"Ralston","year":"2006","journal-title":"PLoS Med"},{"key":"key20180108133137_b17-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1359\/jbmr.080814","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with spinal BMD in 9-year-old children","volume":"24","author":"Steer","year":"2009","journal-title":"J Bone Miner Res"},{"key":"key20180108133137_b18-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa0801197","article-title":"Multiple genetic loci for bone mineral density and fractures","volume":"358","author":"Styrkarsdottir","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108133137_b19-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bone.2005.08.005","article-title":"MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men-results from the odense androgen study","volume":"38","author":"Abrahamsen","year":"2006","journal-title":"Bone"},{"key":"key20180108133137_b20-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/sj.leu.2401965","article-title":"Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric oncology group studies from 1986\u20131994","volume":"14","author":"Maloney","year":"2000","journal-title":"Leukemia"},{"key":"key20180108133137_b21-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"The in vivo response on corticosteroid therapy as an additional prognostic factor in childhood acute lymphoblastic leukemia (therapy study ALL-BFM 83)","volume":"199","author":"Riehm","year":"1987","journal-title":"Klin Padiatr"},{"key":"key20180108133137_b22-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","article-title":"Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86","volume":"84","author":"Reiter","year":"1994","journal-title":"Blood"},{"key":"key20180108133137_b23-etm-0-0-3391","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM study group","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"key20180108133137_b24-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"key":"key20180108133137_b25-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/leu.2008.22","article-title":"Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Is it possible to avoid MRD testing?","volume":"22","author":"Fronkova","year":"2008","journal-title":"Leukemia"},{"key":"key20180108133137_b26-etm-0-0-3391","journal-title":"National Cancer Institute Common toxicity criteria manual"},{"key":"key20180108133137_b27-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s100380300000","article-title":"Genotype and haplotype distributions of MTHFR677C>T and 1298A>C single nucleotide polymorphisms: A meta-analysis","volume":"48","author":"Ogino","year":"2003","journal-title":"J Hum Genet"},{"key":"key20180108133137_b28-etm-0-0-3391","first-page":"747","article-title":"Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia","volume":"88","author":"Aric\u00f2","year":"2003","journal-title":"Haematologica"},{"key":"key20180108133137_b29-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pbc.20244","article-title":"Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)-experiences from trial ALL-BFM 95","volume":"44","author":"Burger","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"key20180108133137_b30-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S8756-3282(02)00822-0","article-title":"In vitro effects of combination chemotherapy on osteoblasts: Implications for osteopenia in childhood malignancy","volume":"31","author":"Davies","year":"2002","journal-title":"Bone"},{"key":"key20180108133137_b31-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2217\/pgs.09.78","article-title":"Individualization of thiopurine therapy: Thiopurine S-methyltransferase and beyond","volume":"10","author":"Karas-Kuzelicki","year":"2009","journal-title":"Pharmacogenomics"},{"key":"key20180108133137_b32-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: Old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J Clin Invest"},{"key":"key20180108133137_b33-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.81B2.8818","article-title":"Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis","volume":"81","author":"Hernigou","year":"1999","journal-title":"J Bone Joint Surg Br"},{"key":"key20180108133137_b34-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00029330-200604010-00012","article-title":"Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: Mechanism of steroid-induced osteonecrosis","volume":"119","author":"Yin","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"key20180108133137_b35-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/leu.2008.217","article-title":"Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis","volume":"22","author":"Muller","year":"2008","journal-title":"Leukemia"},{"key":"key20180108133137_b36-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bone.2009.09.033","article-title":"Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism","volume":"46","author":"Vaes","year":"2010","journal-title":"Bone"},{"key":"key20180108133137_b37-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"key20180108133137_b38-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1359\/jbmr.2002.17.11.2048","article-title":"ER-alpha Genetics Meta-Analysis: Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: A meta-analysis","volume":"17","author":"Ioannidis","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key20180108133137_b39-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00223-003-0168-4","article-title":"Estrogen receptor alpha gene polymorphisms and bone mineral density in healthy children and young adults","volume":"74","author":"Boot","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"key20180108133137_b40-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archneur.57.2.236","article-title":"Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease","volume":"57","author":"Maruyama","year":"2000","journal-title":"Arch Neurol"},{"key":"key20180108133137_b41-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI11468","article-title":"The mechanisms of estrogen regulation of bone resorption","volume":"106","author":"Riggs","year":"2000","journal-title":"J Clin Invest"},{"key":"key20180108133137_b42-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3324\/haematol.2009.016303","article-title":"Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia","volume":"95","author":"te Winkel","year":"2010","journal-title":"Haematologica"},{"key":"key20180108133137_b43-etm-0-0-3391","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: Concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3391\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T03:55:47Z","timestamp":1600660547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,5,25]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/etm.2016.3391"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3391","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}